Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue
John Holdren, Director of the White House Office of Science and Technology, told ScienceBusiness the large one-off increase in science funding in the American Recovery and Reinvestment Act of 2009 has delivered in terms of new facilities and research outputs.
Forget bank bailouts, investment in innovative sectors like IT, medical devices and biotech will be important in rescuing the US economy. Here’s how John McCain and Barack Obama would apply science and innovation policy to solve the economic crisis.